You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

neoprofen Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Neoprofen, and when can generic versions of Neoprofen launch?

Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in NEOPROFEN is ibuprofen lysine. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Neoprofen

A generic version of neoprofen was approved as ibuprofen lysine by XGEN PHARMS on March 30th, 2016.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for neoprofen?
  • What are the global sales for neoprofen?
  • What is Average Wholesale Price for neoprofen?
Drug patent expirations by year for neoprofen
Drug Prices for neoprofen

See drug prices for neoprofen

Recent Clinical Trials for neoprofen

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
State University of New York - Downstate Medical CenterPhase 2
Food and Drug Administration (FDA)Phase 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 2

See all neoprofen clinical trials

Pharmacology for neoprofen
Paragraph IV (Patent) Challenges for NEOPROFEN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NEOPROFEN Injection ibuprofen lysine 10 mg/mL, 2 mL vials 021903 1 2010-10-01

US Patents and Regulatory Information for neoprofen

neoprofen is protected by one US patents.

Patents protecting neoprofen

Ibuprofen compositions and methods of making same
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare NEOPROFEN ibuprofen lysine INJECTABLE;INTRAVENOUS 021903-001 Apr 13, 2006 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for neoprofen

See the table below for patents covering neoprofen around the world.

Country Patent Number Title Estimated Expiration
Germany 60209269 ⤷  Sign Up
Japan 2002326929 METHOD FOR PREVENTING RETINOPATHY OF PREMATURITY IN HEWBORN INFANT ⤷  Sign Up
Germany 60110185 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for neoprofen

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1781277 PA2024501 Lithuania ⤷  Sign Up PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.